Skip to Content, Skip to Navigation
Advertisement

Safeguard OSH Solutions - Thomson Reuters

Safeguard OSH Solutions - Thomson Reuters



Safeguard Magazine

Community—Smart drugs

So-called smart drugs that allow people to maintain concentration and alertness for extended periods are an emerging issue for workplaces, says Professor Brian Bloomfield (pictured) from Lancaster University’s Management School. Speaking at a seminar hosted by AUT’s NZ Work Research Institute, he said drugs like the narcolepsy treatment Modafinil – marketed in New Zealand as Modavigil – are being used, usually without medical supervision, to enhance performance and endurance in high pressure work situations. Some studies have found significant benefits from such use, but others have found few advantages and identified potentially serious side issues, including over-confidence and uncooperative behaviour. Anecdotal evidence suggests use is increasing in competitive work situations, and Bloomfield says the belief that co-workers are using is persuading others to do so, to prevent their colleagues gaining a perceived competitive edge.

Thomson Reuters

comments powered by Disqus

From Safeguard Magazine

Table of Contents